A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Participants With Myelofibrosis (opens ClinicalTrials.gov)
- Sponsor
- Geron Corporation
- Enrolment
- 30
- Started
- 2022-05-04
- Last update
- 2026-08-26
Conditions: Myelofibrosis
Interventions: Imetelstat sodium, Ruxolitinib